Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Assets Average (2016 - 2025)

Historic Assets Average for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $66.9 million.

  • Cumberland Pharmaceuticals' Assets Average fell 1382.2% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year decrease of 1382.2%. This contributed to the annual value of $78.7 million for FY2024, which is 992.65% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Assets Average stood at $66.9 million for Q3 2025, which was down 1382.2% from $68.9 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year Assets Average high stood at $94.9 million for Q1 2021, and its period low was $66.9 million during Q3 2025.
  • In the last 5 years, Cumberland Pharmaceuticals' Assets Average had a median value of $88.2 million in 2021 and averaged $84.6 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Assets Average skyrocketed by 678.43% in 2022, and later tumbled by 1386.36% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Assets Average (Quarter) stood at $86.0 million in 2021, then grew by 6.78% to $91.9 million in 2022, then fell by 7.72% to $84.8 million in 2023, then decreased by 10.14% to $76.2 million in 2024, then fell by 12.16% to $66.9 million in 2025.
  • Its Assets Average stands at $66.9 million for Q3 2025, versus $68.9 million for Q2 2025 and $72.8 million for Q1 2025.